ArticleDiabetes, obesity & metabolism2021

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial.

Geremia B Bolli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.